TLRY
Price
$0.39
Change
-$0.02 (-4.88%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
1.87B
47 days until earnings call
YCBD
Price
$0.98
Change
+$0.01 (+1.03%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
2.62M
Interact to see
Advertisement

TLRY vs YCBD

Header iconTLRY vs YCBD Comparison
Open Charts TLRY vs YCBDBanner chart's image
Tilray Brands
Price$0.39
Change-$0.02 (-4.88%)
Volume$271.57K
Capitalization1.87B
CBDMD
Price$0.98
Change+$0.01 (+1.03%)
Volume$100
Capitalization2.62M
TLRY vs YCBD Comparison Chart
Loading...
TLRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
YCBD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TLRY vs. YCBD commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TLRY is a Hold and YCBD is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (TLRY: $0.39 vs. YCBD: $0.98)
Brand notoriety: TLRY: Notable vs. YCBD: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: TLRY: 128% vs. YCBD: 26%
Market capitalization -- TLRY: $1.87B vs. YCBD: $2.62M
TLRY [@Pharmaceuticals: Other] is valued at $1.87B. YCBD’s [@Pharmaceuticals: Other] market capitalization is $2.62M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TLRY’s FA Score shows that 0 FA rating(s) are green whileYCBD’s FA Score has 0 green FA rating(s).

  • TLRY’s FA Score: 0 green, 5 red.
  • YCBD’s FA Score: 0 green, 5 red.
According to our system of comparison, TLRY is a better buy in the long-term than YCBD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TLRY’s TA Score shows that 4 TA indicator(s) are bullish while YCBD’s TA Score has 6 bullish TA indicator(s).

  • TLRY’s TA Score: 4 bullish, 4 bearish.
  • YCBD’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, YCBD is a better buy in the short-term than TLRY.

Price Growth

TLRY (@Pharmaceuticals: Other) experienced а -16.70% price change this week, while YCBD (@Pharmaceuticals: Other) price change was -1.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.45%. For the same industry, the average monthly price growth was +14.82%, and the average quarterly price growth was +63.61%.

Reported Earning Dates

TLRY is expected to report earnings on Jul 23, 2025.

YCBD is expected to report earnings on May 15, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.45% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TLRY($1.87B) has a higher market cap than YCBD($2.62M). TLRY has higher P/E ratio than YCBD: TLRY (8.52) vs YCBD (0.00). YCBD (-67.820) and TLRY (-70.902) have similar YTD gains . YCBD has higher annual earnings (EBITDA): -3.44M vs. TLRY (-1.23B). TLRY has more cash in the bank: 260M vs. YCBD (1.51M). YCBD has less debt than TLRY: YCBD (3.37M) vs TLRY (529M). TLRY has higher revenues than YCBD: TLRY (700M) vs YCBD (23.4M).
TLRYYCBDTLRY / YCBD
Capitalization1.87B2.62M71,210%
EBITDA-1.23B-3.44M35,861%
Gain YTD-70.902-67.820105%
P/E Ratio8.520.00262,250%
Revenue700M23.4M2,991%
Total Cash260M1.51M17,276%
Total Debt529M3.37M15,702%
FUNDAMENTALS RATINGS
TLRY vs YCBD: Fundamental Ratings
TLRY
YCBD
OUTLOOK RATING
1..100
31
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
60
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9496
PRICE GROWTH RATING
1..100
9497
P/E GROWTH RATING
1..100
9453
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TLRY's Valuation (47) in the Biotechnology industry is in the same range as YCBD (60) in the Other Consumer Services industry. This means that TLRY’s stock grew similarly to YCBD’s over the last 12 months.

TLRY's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as YCBD (100) in the Other Consumer Services industry. This means that TLRY’s stock grew similarly to YCBD’s over the last 12 months.

TLRY's SMR Rating (94) in the Biotechnology industry is in the same range as YCBD (96) in the Other Consumer Services industry. This means that TLRY’s stock grew similarly to YCBD’s over the last 12 months.

TLRY's Price Growth Rating (94) in the Biotechnology industry is in the same range as YCBD (97) in the Other Consumer Services industry. This means that TLRY’s stock grew similarly to YCBD’s over the last 12 months.

YCBD's P/E Growth Rating (53) in the Other Consumer Services industry is somewhat better than the same rating for TLRY (94) in the Biotechnology industry. This means that YCBD’s stock grew somewhat faster than TLRY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TLRYYCBD
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 8 days ago
81%
Bullish Trend 7 days ago
80%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 16 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
TLRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
YCBD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GEGAX14.43N/A
N/A
abrdn Emerging Markets A
VEURX41.48N/A
N/A
Vanguard European Stock Investor
GRERX11.03N/A
N/A
Goldman Sachs Real Estate Securities R
ARSMX9.40N/A
N/A
AMG River Road Small-Mid Cap Value N
ALVDX10.33N/A
N/A
American Century Focused Lg Cap Val R6

YCBD and

Correlation & Price change

A.I.dvisor tells us that YCBD and RGEDF have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that YCBD and RGEDF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To YCBD
1D Price
Change %
YCBD100%
-1.44%
RGEDF - YCBD
28%
Poorly correlated
N/A
TLRY - YCBD
24%
Poorly correlated
+2.17%
DERM - YCBD
24%
Poorly correlated
+3.47%
ACB - YCBD
23%
Poorly correlated
+3.72%
DRRX - YCBD
23%
Poorly correlated
+1.05%
More